Debate: No, Immunotherapy is not the Standard First-line Therapy for mRCC

Date 23 November 2018
Event ESMO Preceptorship on Metastatic Bladder and Kidney Cancer Zurich November 2018
Session Session 4 Debates of the Day
Topics Renal Cell Cancer
Therapy
Presenter C. Porta, IT